Gibbs Lab

20/02/2026

28/01/2026

Bigger than basketball. Every ticket, every donation, and every fundraiser will support crucial research into bowel cancer, from early detection to saving lives.

We can't wait to see you all there 👏

05/01/2026

Exciting things in the works! Stay tuned for more details.

https://www.instagram.com/p/DS8cR7nE_cv/

28/11/2025

Lots of hard work and perseverance by the on display at .

Just a small snapshot of some of the amazing work:

🔎 Dr Margaret Lee presenting on the current status of ctDNA in Australia and what we have learned from the DYNAMIC studies.

🔎 Showcasing analysis of the PURPLE registry data, exploring the differences outcomes post-treatment and the variation in patient care across hospitals.

🔎 Effective utilisation of the TRACC registry data to demonstrate the importance of re-introduction of oxalipatin in unresected mCRC populations or retreatment with an EGFRi.

🔎 Dr Wei Hong highlighting the insights we can gather from different data analyses of registry data.

🔎The value and importance of personalised care plans to ensure patients receive information in an accessible and understandable format.

20/11/2025

Celebrating the public launch of the PURPLE Translational Platform this World Pancreatic Cancer Day! 💜

The PURPLE Translational Platform is a central hub designed to connect patients with the right clinical trials, providing easy access to information on studies actively recruiting around Australia.

The platform integrates the large-scale PURPLE pancreatic cancer clinical registry, which to date has tracked more than 6000 patients across 57 global cancer centres. The PURPLE Registry is led by Dr Belinda Lee and both the progress of the registry, and this momentous launch, represents many years of hard work by the team at . 🌟

Check out the PURPLE Translation Platform here: www.purplepancreas.org.au

More about the platform here: https://www.wehi.edu.au/news/new-platform-to-change-the-story-of-pancreatic-cancer-research/

A game-changing digital platform is bringing together patients, clinicians and researchers to accelerate breakthroughs in pancreatic cancer treatment.